RPG LIFE SCIENCES Financial Statement Analysis
|
||
The Revenues of RPG LIFE SCIENCES have increased by 13.50% YoY .
The Earnings Per Share (EPS) of RPG LIFE SCIENCES has increased by 29.61 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
RPG LIFE SCIENCES Last 5 Annual Financial Results
[BOM: 532983|NSE : RPGLIFE]
Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹582 Cr | ₹513 Cr | ₹440 Cr | ₹389 Cr | ₹376 Cr |
Expenses | ₹453 Cr | ₹409 Cr | ₹353 Cr | ₹318 Cr | ₹316 Cr |
Operating Profit (Excl OI) | ₹129 Cr | ₹104 Cr | ₹87 Cr | ₹71 Cr | ₹60 Cr |
Other Income | ₹7.21 Cr | ₹4.80 Cr | ₹3.08 Cr | ₹1.07 Cr | ₹0.99 Cr |
Interest | ₹1.44 Cr | ₹1.15 Cr | ₹1.41 Cr | ₹1.79 Cr | ₹2.76 Cr |
Depreciation | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Profit Before Tax | ₹118 Cr | ₹92 Cr | ₹73 Cr | ₹54 Cr | ₹36 Cr |
Profit After Tax | ₹88 Cr | ₹68 Cr | ₹51 Cr | ₹40 Cr | ₹29 Cr |
Earnings Per Share (Rs) | ₹53.01 | ₹40.90 | ₹31.13 | ₹24.19 | ₹17.54 |
PAT Margin (%) | 14.05 | 12.19 | 10.74 | 9.53 | 7.06 |
ROE(%) | 25.69 | 24.01 | 21.80 | 20.36 | 17.21 |
ROCE(%) | 34.96 | 32.92 | 31.46 | 27.27 | 20.35 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.01 | 0.07 |
Key Financials |
||
Market Cap | : | ₹ 3,430.4 Cr |
Revenue (TTM) | : | ₹ 618.3 Cr |
Net Profit(TTM) | : | ₹ 70.7 Cr |
EPS (TTM) | : | ₹ 42.8 |
P/E (TTM) | : | 48.5 |
Industry Peers & Returns | 1W | 1M | 1Y |
RPG LIFE SCIENCES | -4.8% | -2.7% | 54.7% |
SUN PHARMACEUTICAL INDUSTRIES | 3.7% | 8.5% | 49.4% |
CIPLA | 3% | 1.9% | 20.9% |
DR REDDYS LABORATORIES | 2.7% | 15.5% | 23.2% |
ZYDUS LIFESCIENCES | -1.6% | 1% | 43.9% |
DIVIS LABORATORIES | 3.6% | 1.8% | 52.1% |
MANKIND PHARMA | -4.9% | 11.4% | 49.2% |
TORRENT PHARMACEUTICALS | -1.4% | 5.3% | 49.3% |
LUPIN | 6.9% | 15.6% | 73.7% |
RPG LIFE SCIENCES Revenues
[BOM: 532983|NSE : RPGLIFE]
Y-o-Y | 13.50 % |
5 Yr CAGR | 11.58 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹582 Cr | 13.50 | |
Mar2023 | ₹513 Cr | 16.51 | |
Mar2022 | ₹440 Cr | 13.11 | |
Mar2021 | ₹389 Cr | 3.61 | |
Mar2020 | ₹376 Cr | - |
RPG LIFE SCIENCES Operating Profit
[BOM: 532983|NSE : RPGLIFE]
Y-o-Y | 24.74 % |
5 Yr CAGR | 21.17 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹129 Cr | 24.74 | |
Mar2023 | ₹104 Cr | 18.78 | |
Mar2022 | ₹87 Cr | 23.16 | |
Mar2021 | ₹71 Cr | 18.15 | |
Mar2020 | ₹60 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 9.91 % |
5 Yr CAGR | 8.60 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 22.19% | 9.91 | |
Mar2023 | 20.19% | 1.97 | |
Mar2022 | 19.8% | 8.85 | |
Mar2021 | 18.19% | 14.04 | |
Mar2020 | 15.95% | - |
RPG LIFE SCIENCES Profit After Tax
[BOM: 532983|NSE : RPGLIFE]
Y-o-Y | 29.60 % |
5 Yr CAGR | 31.84 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹88 Cr | 29.60 | |
Mar2023 | ₹68 Cr | 31.39 | |
Mar2022 | ₹51 Cr | 28.70 | |
Mar2021 | ₹40 Cr | 37.88 | |
Mar2020 | ₹29 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 15.26 % |
5 Yr CAGR | 18.77 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 14.05 % | 15.26 | |
Mar2023 | 12.19 % | 13.50 | |
Mar2022 | 10.74 % | 12.70 | |
Mar2021 | 9.53 % | 34.99 | |
Mar2020 | 7.06 % | - |
RPG LIFE SCIENCES Earnings Per Share (EPS)
[BOM: 532983|NSE : RPGLIFE]
Y-o-Y | 29.61 % |
5 Yr CAGR | 31.85 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹53 | 29.61 | |
Mar2023 | ₹41 | 31.38 | |
Mar2022 | ₹31 | 28.69 | |
Mar2021 | ₹24 | 37.91 | |
Mar2020 | ₹18 | - |
RPG LIFE SCIENCES Return on Capital Employed (ROCE)
[BOM: 532983|NSE : RPGLIFE]
Y-o-Y | 6.20 % |
5 Yr CAGR | 14.49 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 34.96% | 6.20 | |
Mar2023 | 32.92% | 4.64 | |
Mar2022 | 31.46% | 15.36 | |
Mar2021 | 27.27% | 34.00 | |
Mar2020 | 20.35% | - |
RPG LIFE SCIENCES Share Price vs Sensex
Current Share Price | : | ₹2,079.0 |
Current MarketCap | : | ₹ 3,430.4 Cr |
Updated EOD on | : | Dec 30,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
RPG LIFE SCIENCES | -4.8% |
-2.7% |
54.7% |
SENSEX | 0.3% |
-2.5% |
10% |
RPG LIFE SCIENCES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 2.4% | 5% | 46.9% |
S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
S&P BSE SMALL CAP | -0.7% | 0.4% | 30.5% |
S&P BSE MIDSMALLCAP | -2.3% | 1.6% | 31.3% |
You may also like the below Video Courses
FAQ about RPG LIFE SCIENCES Financials
How the annual revenues of RPG LIFE SCIENCES have changed ?
The Revenues of RPG LIFE SCIENCES have increased by 13.50% YoY .
How the Earnings per Share (EPS) of RPG LIFE SCIENCES have changed?
The Earnings Per Share (EPS) of RPG LIFE SCIENCES has increased by 29.61 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs